Meta is rated a Strong Buy, with current valuation dislocation driven by accounting noise and misunderstood CapEx cycles.

What Changed in the Alkermes Price Target Alkermes just saw its fair value estimate nudged from about US$43.88 to US$43.81 per share, a very small trim that reflects only a modest reset in assumptions ...

For patients who do not have strong insurance coverage, that question is not academic, because a single box of pens can cost ...